Loretta Itri
Executive Vice President
Health Management
The Medicines Company
United States of America
Biography
Loretta Itri joined The Medicines Company (MDCO) in 2012 and leads Global Health Science and Regulatory Affairs. Previously, she was President of Pharmaceutical Development and CMO at Genta, Inc., and prior to that she served as Senior Vice President of Medical and Regulatory Affairs at the Robert Wood Johnson Pharmaceutical Research Institute, where she oversaw the development and approval of a variety of therapeutic compounds. In addition, Loretta served as Senior Vice President of Clinical Affairs and CMO for Ortho Biotech Inc., responsible for the hematology, oncology and immunology product lines. She began her career in the pharmaceutical industry at Hoffman-La Roche, where she advanced to the position of AVP of Clinical Development in immunology, virology, hematology, and oncology. Loretta received her medical degree from New York Medical College and completed her medical residency at SUNY-Stony Brook and her fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York.
Research Interest
Clinical Development in immunology, virology, hematology, and oncology
